Emily writes frequently about autism and related issues, and her work has appeared in print or online at Discover, New York Times, Slate, Washington Post, San Francisco Chronicle, and others. Emily has a B.A. in English with minors in German and History and a Ph.D. in biological sciences, both from The University of Texas at Austin. She also completed postdoctoral work at the University of California, San Francisco and has taught graduate and undergraduate biology for many years.
Emily Willingham
Science writer
Spectrum
From this contributor
The legacy of Steve Silberman and his book, ‘NeuroTribes’
The writer’s empathic storytelling changed how society—and researchers—view autistic people.
The legacy of Steve Silberman and his book, ‘NeuroTribes’
By
Emily Willingham
26 September 2024 | 8 min read
Spotted around the web: Week of 29 October 2018
Here is a roundup of news and research for the week of 29 October.
Spotted around the web: Week of 29 October 2018
By
Emily Willingham
2 November 2018 | 5 min read
Book Review: A mother finds reward in risk
In “The Boy Who Loved Too Much,” a woman tries to cocoon her son, who has Williams syndrome, from life’s insults but later realizes her protective instincts carry dangers of their own.
Book Review: A mother finds reward in risk
By
Emily Willingham
30 October 2018 | 5 min read
Spotted around the web: Week of 22 October 2018
Here is a roundup of news and research for the week of 22 October.
Spotted around the web: Week of 22 October 2018
By
Emily Willingham
26 October 2018 | 4 min read
Spotted around the web: Week of 15 October 2018
Here is a roundup of news and research for the week of 15 October.
Spotted around the web: Week of 15 October 2018
By
Emily Willingham
19 October 2018 | 4 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read